Skip to content

Treatment persistence and adherence in patients with Parkinson's disease in Japan: a retrospective observational study using health insurance claim databases

Treatment persistence and adherence in patients with Parkinson's disease in Japan: a retrospective observational study using health insurance claim databases - Treatment persistence and adherence in patients with Parkinson's disease in Japan: a retrospective observational study using health insurance claim databases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000052869
Enrollment
10000
Registered
2023-12-01
Start date
2023-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkison&#39

Interventions

None listed

Sponsors

Eisai Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with Parkinson's disease receiving oral levodopa treatment who began taking an additional Parkinson's disease medication

Exclusion criteria

Exclusion criteria: Patients with a diagnosis of a disease that requires differentiation from Parkinson's disease

Design outcomes

Primary

MeasureTime frame
1) Treatment adherence, and 2) Treatment persistence during 1-year follow-up period

Countries

Japan

Contacts

Public ContactRyosuke Ando

Eisai Co., Ltd. Medical HQs

r2-ando@hhc.eisai.co.jp080-6813-9330

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026